Pulmonary embolism

Critical Care Nursing Quarterly

Volumn 27, Issue 4, 2004, Pages 310-324

  Cardin, Tracy ^a   Marinelli, Anthony ^a  

^a West Suburban Medical Center   (United States)

Author keywords

Clinical symptoms; Diagnosis; Pulmonary embolism; Treatment

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; WARFARIN; XIMELAGATRAN;

BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EMBOLECTOMY; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; MORTALITY; PROGNOSIS; PROPHYLAXIS; REVIEW; RISK FACTOR;

EID: 6344268950     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200410000-00002     Document Type: Review

References (71)

1. Tapson VF. Pulmonary embolism. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jampson JL, eds. Harrison's Principles of Internal Medicine. 15th ed. New York: Mcgraw-Hill; 2002:442-457.
2. Wolfe W. Pulmonary embolism. Ann Surg. 2003; 238:S67-S71.
3. Wood K, Joffe A. Major pulmonary embolism, Part 2: diagnostic confirmation: the role of spiral CT continues to evolve. J Respir Dis. 2003;24(7):1-9.
4. Wood K, Joffe A. Major pulmonary embolism, Part 1: The basic diagnostic studies: syncope may be a telling sign in some patients. J Respir Dis. 2003; 24(6):268-279.
5. Cushman M, Tsai A, Heckbert SR, et al. Incidence rates, case fatality, and recurrence rates of deep vein and thrombosis and pulmonary embolus: the Longitudinal Investigation on Thromboembolism Etiology (LITE). Thromb Haemost. 2001;86(suppl 1):OC 2349.
6. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-462.
7. Siddique RM, Siddique MI, Connors AF Jr, et al. Thirty day case fatality rates for pulmonary embolism in the elderly. Arch Intern Med. 1996;156:2343-2347.
8. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;51:933-935.
9. Silverstein MD, Heit JA, Mohr DV, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585-593.
10. Bounameaux H, Hicklin L, Desmarais S. Seasonal variation in deep vein thrombosis. BMJ. 1996;312:224-285.
11. Gillum RF. Pulmonary embolism and thrombophlebitis in the United States. 1970-1985. Am Heart J. 1987;114:1262-1264.
12. The Pioped Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis. (PIOPED). JAMA. 1990;263(20):2753-2759.
13. Kucher N, Printzen G, Goldhaber S. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003;107:2545-2547.
14. Nicolaides AN, Kakkar VU, Field ES, et al. The origin of deep vein thrombosis: a venographic study. Br J Radiol. 1971;44:653-662.
15. Polak JF. Doppler ultrasound of the deep leg veins: a revolution in the diagnosis of deep vein thrombosis and monitoring of thrombolysis. Chest. 1991;99:1652-1725.
16. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107:122-130.
17. McIntyre KM, Sasahar AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest. 1974;65:534-543.
18. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA. 1976;236:1477-1480.
19. Stein PD, Terrin, ML, Hales CA, et al. Clinical laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no preexisting cardiac or pulmonary disease. Chest. 1991;100:598-603.
20. Anderson FA Jr, Wheeler HB. Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg. 1992;16:707-714.
21. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med. 2003; 349(13):1247-1255.
22. Nicolaides AN, Irving D. Clinical factors and the risk of deep venous thrombosis. In: Nicolaides SA, ed. Thromboembolism Etiology. Advances in Prevention and Management. Baltimore, Md: University Park Press; 1975:193-204.
23. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809-815.
24. Samama MM. Epidemiology of risk factors of deep venous thrombosis of the lower limbs in community practice: the SIRIUS study. Thromb Haemost. 1993;69:763.
25. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003; 107(23):I-17-I-21.
26. Lieberman JS, Borrero J, Urdanetam E, et al. Thrombophlebitis and cancer. JAMA. 1961;177:542-545.
27. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285-291.
28. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23):I9-I16.
29. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med. 1998;338:1169-1173.
30. Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bedrest. Br J Surg. 1957;45:209-236.
31. Scurr JH, Machin SJ, Bailey-Kings S, et al. Frequency and prevention of symptomless deep vein throbosis in long-haul flight: a randomized trial. Lancet. 2001;357:1485-1487.
32. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
33. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003;349:631-703.
34. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409-415.
35. Haage P, Piroth W, Kronbach G, et al. Comparison of angiography with spiral computed tomography, magnetic resonance angiography and real-time magnetic resonance imaging. Am J Respir Crit Care Med. 2003;167:729-739.
36. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med. 2001;135:95-107.
37. Ebell MH. Suspected pulmonary embolism, Part 1: Evidence-based clinical assessment. Am Fam Phys. 2004;69(3):599-601.
38. Kelly J, Rudd A, Lewis R, Hunt B. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 2002;162:747-756.
39. Wicki J, Perneger TV, Junod AF, Bounaneaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med. 2001;161:92-97.
40. Ferrari E, Imbert A, Chevaliar T, et al. The ECG in pulmonary embolism. Predictive value of negative T-waves in precordial leads-80 case reports. Chest. 1997;111:537-543.
41. Giannitsis E, Buterbardorif M, Kurowaki V, et al. Independent prognostic value of cardiac troponin in patients with confirmed pulmonary embolism. Circulation. 2000;102:211-217.
42. Kelly J, Rudd A, Lewis R, Hunt B. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 2002;62:747-756.
43. Stein PD, Terrin, ML, Hales CA, et al. Clinical laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no preexisting cardiac or pulmonary disease. Chest. 1991;100:598-603.
44. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227- 1235.
45. Crippa L, D'Angelo S, Tomassini O, Rizzi B, D'Alessandro G, D'Angelo A. The utility and cost effectiveness of D-dimer measurements in the diagnosis of deep vein thrombosis. Haematoligica. 1997;82:446-451.
46. Stein PD, Coleman RE, Gottschalk A, Saltzman HA, Terrin MC, Weg JG. Diagnostic utility of ventilation/perfusion lung scans in acute pulmonary embolism is not diminished by preexisting cardiac or pulmonary disease. Chest. 1991;100:604-606.
47. Stein PD, Athancisculis C, Hava A, Greenspan RH, Hales CA, Saltzman HA. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85:462-468.
48. Wartski M, Collignon MA. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. J Nucl Med. 2000;41:1043-1048.
49. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;98:591-599.
50. Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest. 2002;122:1440-1456.
51. Stein PD, Athancisculis C, Hava A, Greenspan RH, Hales CA, Saltzman HA. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85:462-468.
52. Rathbun SW, Raskob GE, Whtisett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med. 2000;132:227-232.
53. Ruiz CP, Caniego JL, et al. Prospective comparison of helical CT with angiography in pulmonary embolism: global and selective vascular territory analysis: Interobserver agreement. Eur Radiol. 2003;13:823-829.
54. van Strijen MJL, de Monye W, Schiereck J, et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multi-center clinical management study of 510 patients. Ann Intern Med. 2003;138:301-314.
55. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157:2562-2568.
56. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin. Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:64S-94S.
57. Shapiro SS. Treating thrombosis in the 21st century. N Engl J Med. 2003;349:1762-1764.
58. Konstantinides S, Geibel A, Heusei G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150.
59. The Matisse Investigators. Subcutaneous fondaprinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695-1702.
60. Bauer KA, Bengt EI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305-1310.
61. Bengt EI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345:1298-1304.
62. Hyers T. Management of venous thromboembolism: past, present, and future. Arch Intern Med. 2003;163:759-768.
63. Nurmohamed MT, Rosendaal FR, Buller HT, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surger: a meta-analysis. Lancet. 1992;340:152-156.
64. Breddin HK, Hack-Wunderle V, Nakov R, et al. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med. 2001;344:626-631.
65. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
66. Francis CW, Berkowitz SD, Comp PC, et al. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003;349:1703-1721.
67. Thrombolytic therapy for pulmonary embolism. Is it effective? Is it safe? When is it indicated? [commentary]. Arch Intern Med. 1997;157:2550-2555.
68. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143-1150.
69. Aklog L, Willisams CS, Byrne JG, et al. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002;105:1416-1419.
70. Buller HR, Prins MH. Secondary prophylaxis with warfarin for venous thromboembolism. N Engl J Med. 2003;349:702-703.
71. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic dep venous thrombosis. N Engl J Med. 2001;345:165.